HIKAL
|
The Current P/B Ratio of HIKAL is 2.23.
| Share Price | ₹217.1 | Jul 28,2026 |
| Market Cap | ₹2,676.2 Cr | |
| Book Value | ₹1,198.8 Cr | Mar2026 - Consolidated Results |
| Price/Book | 2.23x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of HIKAL
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹2,676.2 Cr] as on Jul 28,2026
(/) Book Value [ ₹1,198.8 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 2.23x ]
Thus, for HIKAL , the investors are currently willing to pay '2.23 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of HIKAL !
The chart below summarizes the trend in P/B Ratio of HIKAL over the last five years.
Historical PB (Price/Book ) ratio chart of HIKAL
PB Ratio Performance Analysis for HIKAL
- HIKAL 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 3.26x.
- HIKAL 's operated at median p/b ratio of 3.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, HIKAL 's p/b ratio peaked in Mar2022 at 4.65x.
- HIKAL 's p/b ratio hit its five-year low in Mar2021 of 1.9x.
How does HIKAL 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| HIKAL | 1,198.80 | 2.23 | 2,676.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.68 | 474,396.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 11.75 | 196,990.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.22 | 186,354.0 |
| CIPLA LTD | 34,369.40 | 3.40 | 116,705.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.51 | 94,790.0 |
| MANKIND PHARMA LTD | 16,252.60 | 6.65 | 108,129.0 |
| LUPIN LTD | 22,384.10 | 4.89 | 109,494.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.05 | 109,686.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.35 | 89,212.3 |
| LAURUS LABS LTD | 5,275.08 | 18.01 | 94,986.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs HIKAL 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.23x |
| Max industry PB | 22.22x |
| Median industry PB | 4.89x |
| Average industry PB | 7.61x |
You may also like the below Video Courses